Drug Insights

Your Ultimate Guide to Finding Clonazepam on Synapse

9 February 2024
2 min read

KLONOPIN (clonazepam) is a benzodiazepine medication that was first approved by the FDA in 1975 for the treatment of seizure disorders and panic disorder. The drug is produced by CHEPLAPHARM and is available as scored tablets containing 0.5 mg of clonazepam, and unscored tablets containing 1 mg or 2 mg of clonazepam. Clonazepam is a GABAA receptor agonist, which means that it enhances the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that slows down brain activity, resulting in its calming effects. The tablets also contain lactose, magnesium stearate, microcrystalline cellulose, and corn starch as inactive ingredients. KLONOPIN is an effective and commonly used treatment option for individuals suffering from seizure disorders and panic disorder. Click on the image below to begin the exploration journey of Clonazepam through the Synapse database!

图形用户界面, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

US and Japan Approve BMS's Breyanzi Filings for Recurrent Lymphomas
Latest Hotspot
3 min read
US and Japan Approve BMS's Breyanzi Filings for Recurrent Lymphomas
9 February 2024
U.S. and Japanese authorities have approved filings for Bristol Myers Squibb's Breyanzi, aimed at treating recurrent Follicular and Mantle Cell Lymphomas.
Read →
Explore Sildenafil on Synapse: Tips and Tricks for Better Search Results
Drug Insights
2 min read
Explore Sildenafil on Synapse: Tips and Tricks for Better Search Results
9 February 2024
Viagra relaxes muscles found in the walls of blood vessels and increases blood flow to particular areas of the body.
Read →
Vertex Announces Promising Phase 3 Results of VX-548 for Acute Pain Management
Latest Hotspot
4 min read
Vertex Announces Promising Phase 3 Results of VX-548 for Acute Pain Management
9 February 2024
Vertex Reveals Encouraging Outcomes from Phase 3 Trials of VX-548 for Moderate to Intense Short-Term Pain Management.
Read →
Strategically Search Citalopram on Synapse: A How-to Guide
Drug Insights
2 min read
Strategically Search Citalopram on Synapse: A How-to Guide
9 February 2024
Citalopram was approved for medical use in the United States in 1998. It is on the World Health Organization's List of Essential Medicines.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.